Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "Mental"

1193 News Found

PM Modi inaugurates AIIMS Jammu
News | February 21, 2024

PM Modi inaugurates AIIMS Jammu

The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government


Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur
News | February 21, 2024

Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur

The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today


Scandron receives India's first logistics drone type-certification from DGCA
Supply Chain | February 20, 2024

Scandron receives India's first logistics drone type-certification from DGCA

The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions


European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis
Drug Approval | February 20, 2024

European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis

VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU


Biocon included in S&P Global Sustainability Yearbook 2024
Sustainability | February 20, 2024

Biocon included in S&P Global Sustainability Yearbook 2024

Sustainability is integral to Biocon's business purpose


Marksans Q3 FY24 revenue up 22% at Rs 586 Cr
News | February 16, 2024

Marksans Q3 FY24 revenue up 22% at Rs 586 Cr

Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%


Sun Pharma included in S&P Global Sustainability Yearbook 2024
Sustainability | February 13, 2024

Sun Pharma included in S&P Global Sustainability Yearbook 2024

This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses


MIRA Pharmaceuticals announces collaboration with Pharmaseed
News | February 08, 2024

MIRA Pharmaceuticals announces collaboration with Pharmaseed

Studies will Investigate Antidepressant Properties of Ketamir to Position for Initial IND Application in 2024


Glenmark partners Pfizer to launch Abrocitinib in India
Drug Approval | February 01, 2024

Glenmark partners Pfizer to launch Abrocitinib in India

Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India


Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Drug Approval | January 31, 2024

Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours

Submission to be reviewed under FDA real-time oncology review and Project Orbis